Shangwei Lu
Jinan, 250021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
LncRNA ENST00000532153.1 alleviates podocyte injury by inhibiting PARP1-mediated PARylation of ATF3 in diabetic kidney disease.
Journal: Cellular and molecular life sciences : CMLS
Published: April 22, 2025
TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease.
Journal: Kidney international
Published: July 13, 2024
The causal role between circulating immune cells and diabetic nephropathy: a bidirectional Mendelian randomization with mediating insights.
Journal: Diabetology & metabolic syndrome
Published: April 09, 2024
Mitochondrial metabolic reprogramming in diabetic kidney disease.
Journal: Cell death & disease
Published: March 12, 2024
The inhibition of ZC3H13 attenuates G2/M arrest and apoptosis by alleviating NABP1 m6A modification in cisplatin-induced acute kidney injury.
Journal: Cellular and molecular life sciences : CMLS
Published: March 11, 2024
N6-methyladenosine methylation in kidney injury.
Journal: Clinical epigenetics
Published: September 01, 2023
Inhibition of the lncRNA 585189 prevents podocyte injury and mitochondria dysfunction by promoting hnRNP A1 and SIRT1 in diabetic nephropathy.
Journal: Molecular and cellular endocrinology
Published: June 23, 2023
T cells and their products in diabetic kidney disease.
Journal: Frontiers in immunology
Published: October 30, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026